“Slowing Nephropathy in Patients with Type 2 Diabetes: Is there hope?” By Steven Coca, DO, MS Assistant Professor of Medicine Yale University School of Medicine New Haven, CT
Please join us for Medicine Grand Rounds on Friday, June 27, 2014 for the presentation titled:
“Slowing Nephropathy in Patients with Type 2 Diabetes: Is there hope?”
Steven Coca, DO, MS
Assistant Professor of Medicine
Yale University School of Medicine
New Haven, CT
8:00 a.m. – 9:00 a.m.
Auditorium E, Rubin Building, Dartmouth-Hitchcock Medical Center
Co-sponsored by Endocrinology and the Department of Medicine
Geisel School of Medicine at Dartmouth
Objectives – Participants will be able to:
1. Identify the impact of intensive glycemic control and single and dual-blockade of the renin-angiotensin-aldosterone system on renal outcomes in patients with type 2 diabetes
2. Examine the dissociation between surrogate and hard outcomes in several recent trials in patients with diabetic kidney disease
3. Discuss how utilization of newer markers of tubulointerstitial kidney injury and inflammation may improve risk stratification and assist in finding signals of efficacy of new agents
Steven Coca, DO. MS
Dr. Coca is an Assistant Professor of Medicine at Yale University School of Medicine in New Haven, CT. He obtained an MS degree in Epidemiology and Public Health from the Yale Graduate School of Arts and Sciences in 2009.
Dr. Coca is an investigator in the Yale Program of Applied Translational Research, and has active funding and projects related to acute and chronic kidney disease. He received a K23 award from the NIDDK in 2008 and is the PI of a multi-center project (1R01DK096549) to examine the ability for biomarkers to predict progression of Diabetic Kidney Disease in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study population. He is a co-investigator in the Translational Research In Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) consortium since 2005 and also a co-investigator in The ASsessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) consortium (NIDDK-sponsored UO1 Consortium) to study the natural history of AKI with longitudinal follow-up.
Steven Coca, DO, MS has stated that he has no financial interests or arrangements in association with this presentation.
Please join the Department of Medicine in welcoming Dr. Steven Coca to Medicine Grand Rounds.
IMPORTANT: Please complete the Medicine Grand Rounds Evaluation form to be submitted in clear, LEGIBLE PRINT with ALL information requested including: Full Name / Department / Email & Address if other than DHMC. The office of Continuing Medical Education will not be able to give you credit unless all fields are filled out completely. Thank you for your cooperation.
If you are unable to attend and would like to either view Grand Rounds live on your computer or if you would like to view it another time, please use this link. http://med.dartmouth-hitchcock.org/education/dept_medicine_grand_rounds_live.html
*PLEASE NOTE: Credit will only be awarded for written evaluations submitted within 1 week of conference date.
Events are free and open to the public unless otherwise noted.